Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Non Operating Income: 2023-2025

Historic Non Operating Income for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $1.6 million.

  • Compass Therapeutics' Non Operating Income fell 11.38% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 26.94%. This contributed to the annual value of $7.2 million for FY2024, which is 7.87% down from last year.
  • Compass Therapeutics' Non Operating Income amounted to $1.6 million in Q3 2025, which was up 31.48% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Compass Therapeutics' Non Operating Income ranged from a high of $2.1 million in Q2 2023 and a low of $1.2 million during Q2 2025.
  • For the 3-year period, Compass Therapeutics' Non Operating Income averaged around $1.7 million, with its median value being $1.9 million (2023).
  • As far as peak fluctuations go, Compass Therapeutics' Non Operating Income increased by 5.82% in 2024, and later plummeted by 39.82% in 2025.
  • Quarterly analysis of 3 years shows Compass Therapeutics' Non Operating Income stood at $2.0 million in 2023, then fell by 22.09% to $1.5 million in 2024, then fell by 11.38% to $1.6 million in 2025.
  • Its Non Operating Income was $1.6 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.3 million in Q1 2025.